Reuters logo
10 个月前
BRIEF-Imprimis reports availability of lower-cost option for the treatment of lead poisoning
2016年10月17日 / 下午12点47分 / 10 个月前

BRIEF-Imprimis reports availability of lower-cost option for the treatment of lead poisoning

Oct 17 (Reuters) - Imprimis Pharmaceuticals Inc :

* Imprimis Pharmaceuticals announces availability of lower-cost option for the treatment of lead poisoning

* Imprimis - Imprimis' compounded EDTA calcium disodium injection is priced at $495 for a five-day treatment Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below